TCR2 Therapeutics Inc. Operating Income 2019-2023 | TCRR
TCR2 Therapeutics Inc. operating income from 2019 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| TCR2 Therapeutics Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2022 | $-153 |
| 2021 | $-100 |
| 2020 | $-69 |
| 2019 | $-51 |
| 2018 | $-26 |
| 2017 | $-13 |
| 2016 | $-10 |
| TCR2 Therapeutics Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2023-03-31 | $-42 |
| 2022-12-31 | $-61 |
| 2022-09-30 | $-31 |
| 2022-06-30 | $-32 |
| 2022-03-31 | $-29 |
| 2021-12-31 | $-28 |
| 2021-09-30 | $-26 |
| 2021-06-30 | $-24 |
| 2021-03-31 | $-22 |
| 2020-12-31 | $-19 |
| 2020-09-30 | $-17 |
| 2020-06-30 | $-17 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-14 |
| 2019-09-30 | $-15 |
| 2019-06-30 | $-12 |
| 2019-03-31 | $-11 |
| 2018-12-31 | $-8 |
| 2018-09-30 | $-7 |
| 2018-06-30 | $-7 |
| 2018-03-31 | $-4 |
